title: The formation of viroplasm-like structures by the rotavirus NSP5 protein is calcium regulated and directed by a C-terminal helical domain.
abstract: The rotavirus NSP5 protein directs the formation of viroplasm-like structures (VLS) and is required for viroplasm formation within infected cells. In this report, we have defined signals within the C-terminal 21 amino acids of NSP5 that are required for VLS formation and that direct the insolubility and hyperphosphorylation of NSP5. Deleting C-terminal residues of NSP5 dramatically increased the solubility of N-terminally tagged NSP5 and prevented NSP5 hyperphosphorylation. Computer modeling and analysis of the NSP5 C terminus revealed the presence of an amphipathic alpha-helix spanning 21 C-terminal residues that is conserved among rotaviruses. Proline-scanning mutagenesis of the predicted helix revealed that single-amino-acid substitutions abolish NSP5 insolubility and hyperphosphorylation. Helix-disrupting NSP5 mutations also abolished localization of green fluorescent protein (GFP)-NSP5 fusions into VLS and directly correlate VLS formation with NSP5 insolubility. All mutations introduced into the hydrophobic face of the predicted NSP5 alpha-helix disrupted VLS formation, NSP5 insolubility, and the accumulation of hyperphosphorylated NSP5 isoforms. Some NSP5 mutants were highly soluble but still were hyperphosphorylated, indicating that NSP5 insolubility was not required for hyperphosphorylation. Expression of GFP containing the last 68 residues of NSP5 at its C terminus resulted in the formation of punctate VLS within cells. Interestingly, GFP-NSP5-C68 was diffusely dispersed in the cytoplasm when calcium was depleted from the medium, and after calcium resupplementation GFP-NSP5-C68 rapidly accumulated into punctate VLS. A potential calcium switch, formed by two tandem pseudo-EF-hand motifs (DxDxD), is present just upstream of the predicted alpha-helix. Mutagenesis of either DxDxD motif abolished the regulatory effect of calcium on VLS formation and resulted in the constitutive assembly of GFP-NSP5-C68 into punctate VLS. These results reveal specific residues within the NSP5 C-terminal domain that direct NSP5 hyperphosphorylation, insolubility, and VLS formation in addition to defining residues that constitute a calcium-dependent trigger of VLS formation. These studies identify functional determinants within the C terminus of NSP5 that regulate VLS formation and provide a target for inhibiting NSP5-directed VLS functions during rotavirus replication.
authors: Department of Medicine, SUNY at Stony Brook, Stony Brook, NY 11794, USA.
authors: Adrish
authors: A
authors: Sen
authors: Nandini
authors: N
authors: Sen
authors: Erich R
authors: ER
authors: Mackow
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D002118:Calcium / Q000378:metabolism; D002522:Chlorocebus aethiops; D003593:Cytoplasm / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011392:Proline / Q000737:chemistry; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D012401:Rotavirus / Q000737:chemistry; D017361:Viral Nonstructural Proteins / Q000737:chemistry* / Q000378:metabolism
chemical_list: C434828:NSP5 protein, rotavirus group A; D017361:Viral Nonstructural Proteins; D049452:Green Fluorescent Proteins; D011392:Proline; D002118:Calcium
references: J Virol. 2006 Nov;80(21):10829-35
references: 16928740
references: J Virol. 2005 May;79(10):6194-206
references: 15858004
references: Proteins. 2006 Nov 15;65(3):643-55
references: 16981205
references: J Virol. 2007 Mar;81(5):2128-37
references: 17182692
references: Proteins. 1999 Nov 15;37(3):499-507
references: 10591109
references: J Gen Virol. 2000 Mar;81(Pt 3):821-30
references: 10675420
references: Proteins. 2001 Sep 1;44(4):479-83
references: 11484225
references: J Gen Virol. 2005 Jun;86(Pt 6):1609-17
references: 15914838
references: J Virol. 2005 Aug;79(15):10023-31
references: 16014962
references: J Gen Virol. 2006 Feb;87(Pt 2):429-38
references: 16432031
references: J Virol. 2006 Feb;80(4):1807-16
references: 16439537
references: J Virol. 2006 Jun;80(12):6061-71
references: 16731945
references: Lancet. 2006 Jul 22;368(9532):323-32
references: 16860702
references: J Virol. 2006 Aug;80(16):8283-4; author reply 8284-5
references: 16873287
references: Curr Top Microbiol Immunol. 2006;309:169-87
references: 16909900
references: Curr Top Microbiol Immunol. 2006;309:189-219
references: 16913048
references: J Virol. 2002 Apr;76(7):3461-70
references: 11884570
references: J Cell Sci. 2002 Jun 15;115(Pt 12):2485-95
references: 12045219
references: Arch Virol. 2002 Oct;147(10):1899-911
references: 12376752
references: J Pept Sci. 2003 Jun;9(6):386-92
references: 12846484
references: J Virol. 2003 Nov;77(22):12184-92
references: 14581555
references: J Mol Biol. 2004 Jan 9;335(2):631-40
references: 14672669
references: Virology. 2004 Feb 5;319(1):94-106
references: 14967491
references: J Gen Virol. 2004 Mar;85(Pt 3):625-34
references: 14993647
references: J Mol Biol. 2004 Oct 29;343(4):971-84
references: 15476814
references: J Gen Virol. 2004 Nov;85(Pt 11):3285-90
references: 15483242
references: J Gen Virol. 1982 Dec;63(2):457-67
references: 6296288
references: Virus Res. 1984;1(2):133-52
references: 6099654
references: J Cell Biol. 1986 Feb;102(2):457-68
references: 3511070
references: J Virol. 1989 Sep;63(9):3974-82
references: 2548010
references: J Gen Virol. 1990 Sep;71 ( Pt 9):2073-83
references: 2170574
references: Proteins. 1991;9(1):12-22
references: 2017432
references: Virology. 1991 May;182(1):8-16
references: 1850914
references: J Gen Virol. 1993 Mar;74 ( Pt 3):525-30
references: 8383185
references: J Virol. 1994 Jan;68(1):251-7
references: 8254736
references: J Virol. 1995 Sep;69(9):5763-72
references: 7637021
references: J Biol Chem. 1995 Nov 17;270(46):27876-9
references: 7499261
references: J Gen Virol. 1996 Sep;77 ( Pt 9):2059-65
references: 8811003
references: J Virol. 1997 Jan;71(1):34-41
references: 8985320
references: J Virol. 1997 Jan;71(1):138-44
references: 8985332
references: J Virol. 1998 Aug;72(8):6398-405
references: 9658080
references: Arch Virol. 1998;143(9):1711-22
references: 9787656
references: J Gen Virol. 1998 Nov;79 ( Pt 11):2679-86
references: 9820143
references: Biochem Cell Biol. 1998;76(2-3):313-23
references: 9923700
references: J Gen Virol. 1999 Feb;80 ( Pt 2):333-9
references: 10073692
references: Protein Eng. 1999 May;12(5):395-405
references: 10360980
references: Virology. 1962 Oct;18:192-205
references: 13960197
references: Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16304-9
references: 15520389
references: Biochemistry. 2005 Jan 11;44(1):411-6
references: 15628883
references: Biochemistry. 2005 Jan 25;44(3):905-14
references: 15654746
references: J Gen Virol. 2005 May;86(Pt 5):1481-7
references: 15831961
references: Mem Inst Oswaldo Cruz. 2006 Sep;101(6):603-11
references: 17072471